| Financial Year |
March 31 2023 |
| Monetary Funds |
252,346,181.35 |
| Held-for-trading Financial Assets |
100,000,000.00 |
| Notes Receivable |
14,479,991.88 |
| Accounts Receivable |
129,932,347.05 |
| Advances to Suppliers |
5,656,941.51 |
| Other Receivables |
31,582,560.74 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
43,959,459.98 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
133,894.34 |
| Total Current Assets |
578,091,376.85 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
360,839,206.26 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
29,612,229.83 |
| R&D expenses |
-- |
| Goodwill |
36,472,534.89 |
| Long-Term Deferred and Prepaid Expenses |
1,338,336.66 |
| Deferred Income Tax Assets |
4,642,296.43 |
| Other Non-Current Assets |
4,186,970.29 |
| Sub-Total of Non-Current Assets |
437,091,574.36 |
| Total Assets |
1,015,182,951.21 |
| Short-Term Loans |
50,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
116,496,335.58 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
15,830,193.28 |
| Taxes Payable |
19,476,606.97 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
44,203,139.95 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
191,246.64 |
| Sub-Total of Current Liabilities |
247,668,650.60 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,862,018.00 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
9,126,391.64 |
| Total Liabilities |
256,795,042.24 |
| Paid-In Capital(Or Share Stock) |
190,682,250.00 |
| Capital Surplus |
232,680,262.95 |
| Surplus Reserve |
20,860,834.15 |
| LESS:Treasury Stock |
22,860.00 |
| Undistributed Profits |
309,464,470.76 |
| Minority Stockholder's Interest |
4,817,665.40 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
753,570,243.57 |
| Owner's Equity（Stockholder's Equity） |
758,387,908.97 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,015,182,951.21 |
